EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current State of Knowledge on Medical Cannabis Use and Risk for Infections: A Practical Guide for Clinicians

Kailey Hughes Kramer iD, Will Garner iD, Cornelius J Clancy iD, M Hong Nguyen iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag343 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Kailey Hughes Kramer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Medical Marijuana, Bacterial Infections, Mycoses. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients and clinicians broadly support medical cannabis, but acknowledge limited understanding of products, efficacy, and safety. Here, we review cannabis products, regulatory issues, microbial contamination of cannabis, and infections linked to cannabis. In the United States, cannabis is regulated by a patchwork of federal and state laws. Three pharmaceutical-grade cannabinoids are US Food and Drug Association (FDA)-approved, and non-FDA-approved medical cannabis products are legal in 40 states. There are no uniform standards for testing products for microbes or validated safety thresholds from state to state. Reports of cannabis-associated fungal and bacterial infections have been published. However, only a single case report used genome sequencing to conclusively link a disease-causing fungus (Cryptococcus neoformans) to cannabis consumed by the patient. Therefore, infections can clearly complicate cannabis use, but extent of risk and specific risk factors are unknown. There is urgent need for harmonized cannabis regulation, standardized product testing and safety criteria, and clinical and translational research on infectious risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical MarijuanaBacterial InfectionsMycosesHumansUnited StatesCannabinoidsCannabisRisk Factors

Stichwörter der Autor:innen

cannabisfungusinfectionmarijuanaregulation

Substanzen

Medical MarijuanaCannabinoids

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Kailey Hughes Kramer, Will Garner, Cornelius J Clancy, M Hong Nguyen

Zitieren

APA

Hughes Kramer, K., Garner, W., Clancy, C. J., & Nguyen, M. H. (2026). Current State of Knowledge on Medical Cannabis Use and Risk for Infections: A Practical Guide for Clinicians. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag343

Vancouver

Hughes Kramer K, Garner W, Clancy CJ, Nguyen MH. Current State of Knowledge on Medical Cannabis Use and Risk for Infections: A Practical Guide for Clinicians. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag343

BibTeX
@article{HughesKramer2026,
  author = {Hughes Kramer, Kailey and Garner, Will and Clancy, Cornelius J and Nguyen, M Hong},
  title = {Current State of Knowledge on Medical Cannabis Use and Risk for Infections: A Practical Guide for Clinicians},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag343}
}
Kostenlos starten →